U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

White hair

MedGen UID:
66797
Concept ID:
C0239804
Finding; Finding
SNOMED CT: White hair (297993006)
 
HPO: HP:0011364

Definition

Hypopigmented hair that appears white. [from HPO]

Conditions with this feature

Familial methionine malabsorption
MedGen UID:
78693
Concept ID:
C0268622
Disease or Syndrome
Ermine phenotype
MedGen UID:
346466
Concept ID:
C1856899
Disease or Syndrome
A rare deafness characterized by the association of bilateral sensorineural hearing loss and white hair with scattered black tufts, as well as skin areas of hyper- and hypopigmentation. Additional reported features include global developmental delay and moderate intellectual disability, growth retardation, microcephaly, hypotonia, mild dysmorphic facial features (deeply set eyes, broad nasal bridge, slight bowing of the upper lip), retinal depigmentation, anomalies of the fingers and toes, and white matter abnormalities on brain imaging.
Tyrosinase-negative oculocutaneous albinism
MedGen UID:
1643910
Concept ID:
C4551504
Disease or Syndrome
Researchers have identified multiple types of oculocutaneous albinism, which are distinguished by their specific skin, hair, and eye color changes and by their genetic cause. Oculocutaneous albinism type 1 is characterized by white hair, very pale skin, and light-colored irises. Type 2 is typically less severe than type 1; the skin is usually a creamy white color and hair may be light yellow, blond, or light brown. Type 3 includes a form of albinism called rufous oculocutaneous albinism, which usually affects dark-skinned people. Affected individuals have reddish-brown skin, ginger or red hair, and hazel or brown irises. Type 3 is often associated with milder vision abnormalities than the other forms of oculocutaneous albinism. Type 4 has signs and symptoms similar to those seen with type 2.\n\nOculocutaneous albinism is a group of conditions that affect coloring (pigmentation) of the skin, hair, and eyes. Affected individuals typically have very fair skin and white or light-colored hair. Long-term sun exposure greatly increases the risk of skin damage and skin cancers, including an aggressive form of skin cancer called melanoma, in people with this condition. Oculocutaneous albinism also reduces pigmentation of the colored part of the eye (the iris) and the light-sensitive tissue at the back of the eye (the retina). People with this condition usually have vision problems such as reduced sharpness; rapid, involuntary eye movements (nystagmus); and increased sensitivity to light (photophobia).\n\nSeveral additional types of this disorder have been proposed, each affecting one or a few families.
Waardenburg syndrome, IIa 2F
MedGen UID:
1809587
Concept ID:
C5677013
Disease or Syndrome
Waardenburg syndrome type 2F (WS2F) is characterized by congenital or neonatal-onset sensorineural hearing loss and altered pigmentation of the iris, hair, and skin. Variable expressivity has been reported, even among patients with the same mutation (Ogawa et al., 2017; Vona et al., 2022). For a general phenotypic description and discussion of genetic heterogeneity of WS2, as well as a brief description of other clinical variants of Waardenburg syndrome (WS1, 193500; WS3, 148820; and WS4, 277580), see WS2A (193510).

Professional guidelines

Recent clinical studies

Etiology

Godar DE
Curr Probl Dermatol 2021;55:339-353. Epub 2021 Oct 25 doi: 10.1159/000517643. PMID: 34698023
Cervantes J, Fertig RM, Maddy A, Tosti A
Am J Clin Dermatol 2017 Dec;18(6):789-796. doi: 10.1007/s40257-017-0297-6. PMID: 28555441
Fedorkova MV, Brandt NN, Chikishev AY, Smolina NV, Balabushevich NG, Gusev SA, Lipatova VA, Botchey VM, Dobretsov GE, Mikhalchik EV
J Photochem Photobiol B 2016 Nov;164:43-48. Epub 2016 Sep 13 doi: 10.1016/j.jphotobiol.2016.09.021. PMID: 27643983
Sleiman R, Kurban M, Succaria F, Abbas O
J Am Acad Dermatol 2013 Oct;69(4):625-33. Epub 2013 Jul 12 doi: 10.1016/j.jaad.2013.05.022. PMID: 23850259
Tobin DJ, Hordinsky M, Bernard BA
J Investig Dermatol Symp Proc 2005 Dec;10(3):275-9. doi: 10.1111/j.1087-0024.2005.10117.x. PMID: 16382680

Diagnosis

Rangu SA, Oza VS
Pediatr Dermatol 2024 Mar-Apr;41(2):197-203. Epub 2023 Dec 29 doi: 10.1111/pde.15498. PMID: 38156748
Sethi S, Chauhan P, Jindal R, Bisht YS
Indian J Dermatol Venereol Leprol 2021 Jan-Feb;88(1):40-46. doi: 10.25259/IJDVL_11_2020. PMID: 34379967
Millington KR
Int J Cosmet Sci 2020 Jun;42(3):289-301. Epub 2020 May 10 doi: 10.1111/ics.12614. PMID: 32219869
Cervantes J, Fertig RM, Maddy A, Tosti A
Am J Clin Dermatol 2017 Dec;18(6):789-796. doi: 10.1007/s40257-017-0297-6. PMID: 28555441
Kakourou T
World J Pediatr 2009 Nov;5(4):265-8. Epub 2009 Nov 13 doi: 10.1007/s12519-009-0050-1. PMID: 19911140

Therapy

Godar DE
Curr Probl Dermatol 2021;55:339-353. Epub 2021 Oct 25 doi: 10.1159/000517643. PMID: 34698023
Sethi S, Chauhan P, Jindal R, Bisht YS
Indian J Dermatol Venereol Leprol 2021 Jan-Feb;88(1):40-46. doi: 10.25259/IJDVL_11_2020. PMID: 34379967
Alijanpoor R, Poorsattar BejehMir A, Mokmeli S
Photomed Laser Surg 2011 Nov;29(11):773-9. Epub 2011 Jul 8 doi: 10.1089/pho.2010.2940. PMID: 21740277
Seckin D, Yildiz A
Australas J Dermatol 2009 Aug;50(3):214-6. doi: 10.1111/j.1440-0960.2009.00542.x. PMID: 19659987
Van Neste D, Tobin DJ
Micron 2004;35(3):193-200. doi: 10.1016/j.micron.2003.11.006. PMID: 15036274

Prognosis

Sethi S, Chauhan P, Jindal R, Bisht YS
Indian J Dermatol Venereol Leprol 2021 Jan-Feb;88(1):40-46. doi: 10.25259/IJDVL_11_2020. PMID: 34379967
Shima N, Nitta A, Kamata T, Sasaki K, Matsuta S, Ishikawa A, Asai R, Wada M, Kakehashi H, Nakano S, Kamata H, Sato T, Tsuchihashi H, Miki A, Katagi M
Forensic Sci Int 2019 Aug;301:67-75. Epub 2019 May 11 doi: 10.1016/j.forsciint.2019.05.013. PMID: 31129374
Seleit I, Bakry OA, Abdou AG, Dawoud NM
J Eur Acad Dermatol Venereol 2015 Mar;29(3):444-51. Epub 2014 Jun 9 doi: 10.1111/jdv.12573. PMID: 24909913
Sleiman R, Kurban M, Succaria F, Abbas O
J Am Acad Dermatol 2013 Oct;69(4):625-33. Epub 2013 Jul 12 doi: 10.1016/j.jaad.2013.05.022. PMID: 23850259
Kakourou T
World J Pediatr 2009 Nov;5(4):265-8. Epub 2009 Nov 13 doi: 10.1007/s12519-009-0050-1. PMID: 19911140

Clinical prediction guides

Kasmi R, Hagerty J, Young R, Lama N, Nepal J, Miinch J, Stoecker W, Stanley RJ
Skin Res Technol 2023 Apr;29(4):e13203. doi: 10.1111/srt.13203. PMID: 37113095Free PMC Article
Sethi S, Chauhan P, Jindal R, Bisht YS
Indian J Dermatol Venereol Leprol 2021 Jan-Feb;88(1):40-46. doi: 10.25259/IJDVL_11_2020. PMID: 34379967
Shima N, Nitta A, Kamata T, Sasaki K, Matsuta S, Ishikawa A, Asai R, Wada M, Kakehashi H, Nakano S, Kamata H, Sato T, Tsuchihashi H, Miki A, Katagi M
Forensic Sci Int 2019 Aug;301:67-75. Epub 2019 May 11 doi: 10.1016/j.forsciint.2019.05.013. PMID: 31129374
Oliver MA, Marti M, Coderch L, Carrer V, Kreuzer M, Barba C
Skin Res Technol 2019 Jul;25(4):517-525. Epub 2019 Feb 13 doi: 10.1111/srt.12681. PMID: 30758871
Van Neste D, Tobin DJ
Micron 2004;35(3):193-200. doi: 10.1016/j.micron.2003.11.006. PMID: 15036274

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...